Qingquan Company's IPO on the GEM has been inquired. It plans to raise 492.3 million yuan.

On January 14, Jiangsu Qingquan Chemical Co., Ltd. (hereinafter referred to as Qingquan Chemical) applied for a change in the review status of its listing on the ChiNext Board of the Shenzhen Stock Exchange to "Under Inquiry". Guosen is its sponsor institution, and it plans to raise 492.3 million yuan. According to the prospectus, Qingquan Chemical is a national key "little giant" enterprise specializing in the research, production, and sale of special fine chemicals and special polymer new materials, focusing on the preparation of high-polymer new materials and monomers with characteristics such as high transparency, weather resistance, and high temperature resistance, as well as the comprehensive utilization and development of non-grain bio-based material furfural. The company has established four major product systems covering new material monomers, green solvents, pharmaceutical and pesticide intermediates, and special high-polymer new materials, which are widely used in aviation and aerospace, wind power, automotive, electronics, medical equipment, chemical industry, pharmaceuticals, pesticides, and other fields. Starting with furfural as the raw material and gradually extending downstream along the industrial chain through the application of core technology, the company has formed a unique matrix of non-grain bio-based products. During the reporting period, the proportion of the company's non-grain bio-based products in the main business income was 44.77%, 39.65%, 38.64%, and 37.13% respectively. Third-party testing organizations have confirmed that the company's core products, the new material monomer MACM and the green solvent 2-MeTHF, as well as the key promoted products in the OPI series of polyimides and the new material monomer CHDM, have performance standards that meet industry benchmarks and are comparable to those of major competitors in the industry. The company's core products have a strong market competitiveness and industry position within their respective segments. According to reports published by EO Consulting and the company's sales data, the company's MACM product is estimated to hold a global market share of approximately 28% in 2024, and its 2-MeTHF product is estimated to hold a global market share of approximately 19%. In terms of customers, the company actively promotes the industrial application of core technologies, competes directly in the global market, and has gained recognition from well-known domestic and foreign customers such as Zhangye Dagong, Gridda Group, Feiyang Junyan, IMCD Group, Shanghai Huayi Group Corporation, Kyowa Group, Zhongning Hua Group, Asymchem Laboratories, and China Petroleum & Chemical Corporation. The funds raised through this issuance and listing will be invested in projects related to the company's main business. The specific details are as follows: Financially, the operating income of Qingquan Chemical is expected to be approximately 687 million yuan, 713 million yuan, 797 million yuan, and 396 million yuan in the years 2022, 2023, 2024, and the first 6 months of 2025, respectively. During the same period, the net profits are expected to be approximately 52.83 million yuan, 81.82 million yuan, 98.66 million yuan, and 57.91 million yuan respectively.